RPTX
Price
$2.82
Change
+$0.07 (+2.55%)
Updated
Sep 6 closing price
60 days until earnings call
VIGL
Price
$3.42
Change
-$0.34 (-9.04%)
Updated
Sep 6 closing price
60 days until earnings call
Ad is loading...

RPTX vs VIGL

Header iconRPTX vs VIGL Comparison
Open Charts RPTX vs VIGLBanner chart's image
Repare Therapeutics
Price$2.82
Change+$0.07 (+2.55%)
Volume$65.62K
CapitalizationN/A
Vigil Neuroscience
Price$3.42
Change-$0.34 (-9.04%)
Volume$66.98K
CapitalizationN/A
View a ticker or compare two or three
RPTX vs VIGL Comparison Chart
Loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
RPTX vs. VIGL commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTX is a Hold and VIGL is a StrongSell.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (RPTX: $2.76 vs. VIGL: $3.77)
Brand notoriety: RPTX and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RPTX: 50% vs. VIGL: 71%
Market capitalization -- RPTX: $119.7M vs. VIGL: $135.59M
RPTX [@Biotechnology] is valued at $119.7M. VIGL’s [@Biotechnology] market capitalization is $135.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RPTX’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • RPTX’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, both RPTX and VIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RPTX’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 5 bullish TA indicator(s).

  • RPTX’s TA Score: 4 bullish, 6 bearish.
  • VIGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than RPTX.

Price Growth

RPTX (@Biotechnology) experienced а -8.31% price change this week, while VIGL (@Biotechnology) price change was +9.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

RPTX is expected to report earnings on Nov 06, 2024.

VIGL is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($136M) has a higher market cap than RPTX($120M). VIGL YTD gains are higher at: 11.538 vs. RPTX (-62.192). VIGL (-89.62M) and RPTX (-93.8M) have comparable annual earnings (EBITDA) . RPTX has more cash in the bank: 208M vs. VIGL (86.7M). RPTX has less debt than VIGL: RPTX (2.18M) vs VIGL (13.4M). RPTX has higher revenues than VIGL: RPTX (68.7M) vs VIGL (0).
RPTXVIGLRPTX / VIGL
Capitalization120M136M88%
EBITDA-93.8M-89.62M105%
Gain YTD-62.19211.538-539%
P/E RatioN/AN/A-
Revenue68.7M0-
Total Cash208M86.7M240%
Total Debt2.18M13.4M16%
TECHNICAL ANALYSIS
Technical Analysis
RPTXVIGL
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOF0.100.01
+5.32%
Blue Biofuels Inc.
WRDLY4.670.13
+2.76%
Worldline SA
BXBLY24.660.30
+1.21%
Brambles, Ltd.
HENKY20.710.03
+0.12%
Henkel AG & Co. KGAA
RHHBY40.64-0.31
-0.76%
Roche Holding Ltd

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with HRTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-0.36%
HRTX - RPTX
41%
Loosely correlated
+1.69%
ALNY - RPTX
38%
Loosely correlated
-0.70%
AXON - RPTX
37%
Loosely correlated
-0.14%
CRNX - RPTX
36%
Loosely correlated
-3.45%
ARCT - RPTX
35%
Loosely correlated
-1.26%
More

VIGL and

Correlation & Price change

A.I.dvisor tells us that VIGL and TTNP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VIGL and TTNP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
+10.88%
TTNP - VIGL
31%
Poorly correlated
N/A
RPTX - VIGL
29%
Poorly correlated
-0.36%
VIR - VIGL
27%
Poorly correlated
+0.72%
DOMH - VIGL
26%
Poorly correlated
+1.14%
TNYA - VIGL
26%
Poorly correlated
-0.61%
More